Who says we only bring bad news about layoffs? If rosy forecasts are to be believed, Gilead Sciences plans to add 1,900 jobs over 10 years as it nearly doubles the office and R&D space at its Foster City, California, headquarters, according to The San Francisco Business Times.

The biotech wants to raze eight office and R&D buildings and construct up to seven new buildings — as many as three eight- to 10-story office buildings and up to four new two- to four-story laboratory buildings, including manufacturing and pilot production, the paper writes, to house its hopes for expanding beyond the AIDS market into pulmonary and cardiovascular meds.

The plan would increase its Foster City workforce from 1,200 in 2007 to 3,100 in 2017. Right now, Gilead has more than 3,200 employees worldwide, and expects to double its workforce in Seattle and Durham, North Carolina, over the next 10 years as well, according to John Milligan, Gilead’s president.

This is an interesting contrast to the overwhelming industry trend involving job losses, as you can see from the last tally we compiled of layoffs. (Read the comments from readers who have updated the April figures).